v3.24.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating activities      
Net income $ 11,339 $ 8,317 $ 2,590
Adjustments to reconcile net income to net cash provided by operating activities      
Depreciation and amortization 12,919 12,818 13,651
Stock-based compensation expense 649 667 595
Deferred income tax expense 3,120 2,600 492
Bad debt expense 1,192 898 1,026
Losses from sales of receivables 62 165 214
Impairment expense 0 0 477
Loss on remeasurement of disposal group held for sale 0 9 377
Changes in operating assets and liabilities      
Accounts receivable (3,088) (5,038) (5,158)
Equipment installment plan receivables (523) 170 (1,184)
Inventory 131 197 744
Operating lease right-of-use assets 3,480 3,721 5,227
Other current and long-term assets (411) (358) (754)
Accounts payable and accrued liabilities (2,041) (1,126) 558
Short- and long-term operating lease liabilities (3,879) (3,785) (2,947)
Other current and long-term liabilities (678) (839) 459
Other, net 21 143 414
Net cash provided by operating activities 22,293 18,559 16,781
Investing activities      
Purchases of property and equipment, including capitalized interest of $(34), $(104) and $(61) (8,840) (9,801) (13,970)
Purchases of spectrum licenses and other intangible assets, including deposits (3,471) (1,010) (3,331)
Proceeds from sales of tower sites 0 12 9
Proceeds related to beneficial interests in securitization transactions 3,579 4,816 4,836
Acquisition of companies, net of cash acquired (373) 0 (52)
Other, net 33 154 149
Net cash used in investing activities (9,072) (5,829) (12,359)
Financing activities      
Proceeds from issuance of long-term debt 8,587 8,446 3,714
Repayments of financing lease obligations (1,367) (1,227) (1,239)
Repayments of long-term debt (5,073) (5,051) (5,556)
Repurchases of common stock (11,228) (13,074) (3,000)
Dividends on common stock (3,300) (747) 0
Tax withholdings on share-based awards (269) (297) (243)
Other, net (165) (147) (127)
Net cash used in financing activities (12,815) (12,097) (6,451)
Change in cash and cash equivalents, including restricted cash and cash held for sale 406 633 (2,029)
Cash and cash equivalents, including restricted cash and cash held for sale      
Beginning of period 5,307 4,674 6,703
End of period $ 5,713 $ 5,307 $ 4,674